关注
Burak Ozgur
Burak Ozgur
PhD fellow, University of Copenhagen, Denmark
在 sund.ku.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transendothelial electrical resistance measurement across the blood–brain barrier: a critical review of methods
JP Vigh, A Kincses, B Ozgür, FR Walter, AR Santa-Maria, S Valkai, ...
Micromachines 12 (6), 685, 2021
872021
Hypoxia increases expression of selected blood–brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial …
B Ozgür, HCC Helms, E Tornabene, B Brodin
Fluids and Barriers of the CNS 19 (1), 1, 2022
262022
Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid …
C Goldeman, M Andersen, A Al-Robai, T Buchholtz, N Svane, B Ozgür, ...
European Journal of Pharmaceutical Sciences 156, 105577, 2021
172021
Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells
C Goldeman, B Ozgür, B Brodin
Fluids and Barriers of the CNS 17, 1-12, 2020
142020
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model
P Frøslev, H Franzyk, B Ozgür, B Brodin, M Kristensen
European Journal of Pharmaceutical Sciences 168, 106054, 2022
122022
Transendothelial electrical resistance measurement across the blood–brain barrier: a critical review of methods. Micromachines. 2021
JP Vigh, A Kincses, B Ozgür, FR Walter, AR Santa-Maria, S Valkai, ...
92022
Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates
B Ozgür, L Saaby, K Langthaler, B Brodin
European Journal of Pharmaceutical Sciences 112, 112-121, 2018
82018
The cell-penetrating peptide tat facilitates effective internalization of PSD-95 inhibitors into blood–brain barrier endothelial cells but less efficient permeation across the …
EL Al Humaidan, SL Pedersen, A Burkhart, CLM Rasmussen, T Moos, ...
Frontiers in Drug Delivery 2, 854703, 2022
72022
Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain …
B Ozgür, L Saaby, C Janfelt, K Langthaler, E Eneberg, AM Jacobsen, ...
European Journal of Pharmaceutics and Biopharmaceutics 169, 211-219, 2021
62021
Data demonstrating the challenges of determining the kinetic parameters of P-gp mediated transport of low-water soluble substrates
B Ozgür, L Saaby, K Langthaler, B Brodin
Data in brief 16, 655-659, 2018
62018
Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line
B Ozgür, E Puris, A Brachner, A Appelt-Menzel, S Oerter, V Balzer, ...
Fluids and Barriers of the CNS 20 (1), 96, 2023
12023
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
MR Holst, NM de Wit, B Ozgür, A Brachner, K Hyldig, A Appelt-Menzel, ...
Fluids and Barriers of the CNS 20 (1), 82, 2023
12023
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells
N Svane, ABV Pedersen, A Rodenberg, B Ozgür, L Saaby, C Bundgaard, ...
Fluids and Barriers of the CNS 21 (1), 39, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–13